Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析

◆英語タイトル:Mateon Therapeutics Inc (MATN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14890
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting agents. It is developing a product for treatment of anaplastic thyroid cancer, medullary thyroid cancer, stage IV papillary thyroid cancer, ovarian cancer, stage IV follicular thyroid cancer, and others. Mateon offers development pipeline such as CA4P and Oxi4503. The company also conducts multiple clinical trials in oncology to discover small-molecule anticancer agents belong to benzosuberene class of compound. It operates through researchers in the University of Florida and the University of Arhus on anti-angiogenic and anti-metastatic agents. Oxigene is headquartered in South San Francisco, California, the US.

Mateon Therapeutics Inc Key Recent Developments

Nov 14,2018: Mateon Therapeutics announces third quarter 2018 financial results
Aug 14,2018: Mateon Therapeutics reports second quarter 2018 financial results
May 14,2018: Mateon Therapeutics Reports First Quarter 2018 Financial Results
Apr 16,2018: Mateon Therapeutics Reports 2017 Financial Results

This comprehensive SWOT profile of Mateon Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mateon Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mateon Therapeutics Inc – Key Information
Mateon Therapeutics Inc – Overview
Mateon Therapeutics Inc – Key Employees
Mateon Therapeutics Inc – Key Employee Biographies
Mateon Therapeutics Inc – Key Operational Heads
Mateon Therapeutics Inc – Major Products and Services
Mateon Therapeutics Inc – History
Mateon Therapeutics Inc – Company Statement
Mateon Therapeutics Inc – Locations And Subsidiaries
Mateon Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mateon Therapeutics Inc – Business Description
Mateon Therapeutics Inc – Corporate Strategy
Mateon Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Mateon Therapeutics Inc – Strengths
Mateon Therapeutics Inc – Weaknesses
Mateon Therapeutics Inc – Opportunities
Mateon Therapeutics Inc – Threats
Mateon Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Mateon Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mateon Therapeutics Inc, Key Information
Mateon Therapeutics Inc, Key Ratios
Mateon Therapeutics Inc, Share Data
Mateon Therapeutics Inc, Major Products and Services
Mateon Therapeutics Inc, History
Mateon Therapeutics Inc, Key Employees
Mateon Therapeutics Inc, Key Employee Biographies
Mateon Therapeutics Inc, Key Operational Heads
Mateon Therapeutics Inc, Other Locations
Mateon Therapeutics Inc, Subsidiaries
Mateon Therapeutics Inc, Key Manufacturing facilities
Mateon Therapeutics Inc, Key Competitors
Mateon Therapeutics Inc, SWOT Analysis
Mateon Therapeutics Inc, Ratios based on current share price
Mateon Therapeutics Inc, Annual Ratios
Mateon Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Mateon Therapeutics Inc, Performance Chart
Mateon Therapeutics Inc, Ratio Charts

★海外企業調査レポート[Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crossbeta Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Crossbeta Biosciences BV (Crossbeta) is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. It offers screening of oligomer-specific therapeutics and …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向
    Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Vivendi S.A.:戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pretium Packaging, L.L.C.:企業の戦略・SWOT・財務分析
    Pretium Packaging, L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Pretium Packaging, L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • G M Breweries Ltd:企業の戦略・SWOT・財務情報
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tokyo Seimitsu Co., Ltd. (7729):企業の財務・戦略的SWOT分析
    Tokyo Seimitsu Co., Ltd. (7729) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Boryung Pharmaceutical Co Ltd (003850):企業の財務・戦略的SWOT分析
    Summary Boryung Pharmaceutical Co Ltd (Boryung), formerly Boryung Drugs Co Ltd is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE). The company provides major products suc …
  • Tobu Railway Co Ltd:企業の戦略・SWOT・財務情報
    Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Tobu Railway Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industrial and health care sectors. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in industries, including ste …
  • Veidekke ASA (VEI):企業の財務・戦略的SWOT分析
    Veidekke ASA (VEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BioArctic AB (BIOA B):製薬・医療:M&Aディール及び事業提携情報
    Summary BioArctic AB (BioArctic), formerly BioArctic Neuroscience AB, is a biopharma company that develops new immunotherapeutic treatments for patients with central nervous system disorders. The company develops drugs for neurological disorders such as Parkinson’s disease, Alzheimer’s disease and s …
  • Dyadic International Inc (DYAI):企業の財務・戦略的SWOT分析
    Summary Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial en …
  • Eris Lifesciences Ltd (ERIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a health care products and service provider. The company offers glimepride, telmisertan, methylcobalamin and combinations, vitamin d, rabeprazole, olmesartan, mecobalamin colecalciferol, teneligliptin, rosa canina extract, cilnidipine, atorvastati …
  • Hansard Global plc:企業の戦略・SWOT・財務情報
    Hansard Global plc - Strategy, SWOT and Corporate Finance Report Summary Hansard Global plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Thales Holdings UK Plc:企業の戦略・SWOT・財務情報
    Thales Holdings UK Plc - Strategy, SWOT and Corporate Finance Report Summary Thales Holdings UK Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆